This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Nimbalkar, D. Articles by Quelle, F. W. Search for Related Content PubMed PubMed Citation Articles by Nimbalkar, D. Articles by Quelle, F. W.

Cytokine Activation of Phosphoinositide 3-Kinase Sensitizes Hematopoietic Cells to Cisplatin-induced Death¹

Department of Pharmacology [D. N., M. K. H., F. W. Q.] and the Immunology Graduate Program [F. W. Q.], The University of Iowa Carver College of Medicine, Iowa City, Iowa 52242

Cytokine growth factors regulate the normal proliferation of hematopoieticcells but can also override irradiation-induced growth arrest checkpoints through activation of a phosphoinositide 3-kinase (PI3K) signaling pathway. In the present study, we assessed the effect that erythropoietin and interleukin-3 have on cisplatin-treated hematopoietic cells. When cultured in the presence of cytokine, cisplatin-treated 32D cells transiently accumulated in a G₂-M phase arrest and ultimately died by a nonapoptotic mechanism. By comparison, reduction of cytokine-induced PI3K activity, either through cytokine receptor mutation or direct inhibition with LY294002, caused cisplatin-treated cells to enter a biphasic G₁ and G₂-M arrest. The arrest of these cells coincided with an absence of cyclin-dependent kinase (Cdk)1 and Cdk2 activity and significantly reduced cell death during cisplatin treatment. Indeed, LY294002 treatment during cisplatin exposure allowed the recovery of a viable, proliferating cell population after removal of cisplatin. In contrast, Cdks remained active in the G₂-M-arrested population of cisplatin-treated cells with continuous cytokine activation of PI3K, and even transient exposure to cisplatin resulted in death of the entire population. These data suggest that cytokine activation of PI3K signaling pathways overrides cisplatin-induced growth arrest checkpoints, thereby sensitizing hematopoietic cells to DNA damage-induced death.

This article has been cited by other articles:

				H. Lei and F. W. Quelle FOXO Transcription Factors Enforce Cell Cycle Checkpoints and Promote Survival of Hematopoietic Cells after DNA Damage Mol. Cancer Res., August 1, 2009; 7(8): 1294 - 1303. [Abstract] [Full Text] [PDF]

				S. Maddika, S. Panigrahi, E. Wiechec, S. Wesselborg, U. Fischer, K. Schulze-Osthoff, and M. Los Unscheduled Akt-Triggered Activation of Cyclin-Dependent Kinase 2 as a Key Effector Mechanism of Apoptin's Anticancer Toxicity Mol. Cell. Biol., March 1, 2009; 29(5): 1235 - 1248. [Abstract] [Full Text] [PDF]

				S. Maddika, S. R. Ande, E. Wiechec, L. L. Hansen, S. Wesselborg, and M. Los Akt-mediated phosphorylation of CDK2 regulates its dual role in cell cycle progression and apoptosis J. Cell Sci., April 1, 2008; 121(7): 979 - 988. [Abstract] [Full Text] [PDF]

				A. M. Ramos, C. Fernandez, D. Amran, P. Sancho, E. de Blas, and P. Aller Pharmacologic inhibitors of PI3K/Akt potentiate the apoptotic action of the antileukemic drug arsenic trioxide via glutathione depletion and increased peroxide accumulation in myeloid leukemia cells Blood, May 15, 2005; 105(10): 4013 - 4020. [Abstract] [Full Text] [PDF]

				A. D. Friedman, D. Nimbalkar, and F. W. Quelle Erythropoietin Receptors Associate with a Ubiquitin Ligase, p33RUL, and Require Its Activity for Erythropoietin-induced Proliferation J. Biol. Chem., July 11, 2003; 278(29): 26851 - 26861. [Abstract] [Full Text] [PDF]